Back to News
Market Impact: 0.25
Jazz Prices Upsized $1.1 Bln Exchangeable Notes Offering, Plans $225 Mln Share Repurchase
Source: Nasdaq
Company FundamentalsCorporate Earnings
Jazz Pharmaceuticals priced an upsized private offering of $1.1B aggregate principal amount of 1.875% exchangeable senior notes due 2032. The announcement is a financing/capital markets update, with limited directional read-through on fundamentals beyond funding terms.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.05
Ticker Sentiment
JAZZ0.10
More News
- Musk says Terrafab chip factory could outperform rivals despite challenges
- Will Warner Bros. kill Skydance — or will David Ellison kill Warner Bros?
- How Supreme Court justices are leaning in major 401(k) case over private funds and underperformance
- Nvidia GPUs are everywhere. Here are the ways companies are accessing them
- How U.S. know-how is fracking Australia into a gas boom, from Texas oilmen to Trump’s energy secretary
- Cerebras Is About as Big as Nvidia's Data Center Business Was Nearly a Decade Ago. The Similarities Mostly End There.